From https://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
In recent years, drug companies have started releasing details of the payments they make to doctors and other health professionals for promotional talks, research and consulting. As of 2013, 17 companies published the information, most because of legal settlements. Use this tool to search for payments. Read more about the data »
Interested in downloading the data? Go to the ProPublica Data Store.
With 3.5 Million records, this database represents:
$4 billion
in disclosed payments
17
companies
~ 50%
of total market share
Payments in Your State
Click on a state to see payments made to practitioners and institutions there. See notes below.
| State | Total |
| Alabama | $52,323,542 |
| Alaska | $1,060,349 |
| Arizona | $65,450,100 |
| Arkansas | $22,442,598 |
| California | $491,340,883 |
| Colorado | $61,945,908 |
| Connecticut | $54,628,879 |
| Delaware | $6,524,265 |
| District of Columbia | $15,741,004 |
| Florida | $358,882,128 |
| Georgia | $117,922,876 |
| Hawaii | $5,881,572 |
| Idaho | $16,222,755 |
| Illinois | $135,157,148 |
| Indiana | $76,430,761 |
| Iowa | $18,327,523 |
| Kansas | $50,427,854 |
| Kentucky | $48,103,545 |
| Louisiana | $42,349,143 |
| Maine | $6,939,383 |
| Maryland | $104,351,359 |
| Massachusetts | $200,503,955 |
| Michigan | $90,463,442 |
| Minnesota | $55,495,188 |
| Mississippi | $15,723,773 |
| Missouri | $92,939,918 |
| Montana | $5,915,431 |
| Nebraska | $61,649,329 |
| Nevada | $24,873,091 |
| New Hampshire | $9,705,358 |
| New Jersey | $103,296,994 |
| New Mexico | $12,906,740 |
| New York | $265,600,600 |
| North Carolina | $158,418,293 |
| North Dakota | $8,035,907 |
| Ohio | $158,927,259 |
| Oklahoma | $37,606,710 |
| Oregon | $40,014,961 |
| Pennsylvania | $178,719,651 |
| Rhode Island | $21,896,004 |
| South Carolina | $78,304,823 |
| South Dakota | $5,805,158 |
| Tennessee | $84,700,799 |
| Texas | $331,785,758 |
| Utah | $51,588,688 |
| Vermont | $4,264,877 |
| Virginia | $66,111,694 |
| Washington | $66,450,518 |
| West Virginia | $10,829,384 |
| Wisconsin | $44,310,420 |
| Wyoming | $599,722 |
| Puerto Rico | $21,927,260 |
| [Unknown State] | $1,240,470 |
Company Disclosures
The totals listed here cover different time periods and spending categories, and aren't directly comparable. See notes below. See what each company discloses »
| Company | Total Disclosed |
|---|---|
|
AbbVie Disclosed: July 2012 to Dec. 2013 |
$62.6M |
|
Allergan Disclosed: July 2011 to Dec. 2013 |
Ranges* |
|
Amgen Disclosed: Jan. to Dec. 2013 |
$42M |
|
AstraZeneca Disclosed: Jan. 2010 to Dec. 2013 |
$428.2M |
|
Boehringer Ingelheim Disclosed: Jan. to Dec. 2013 |
$99.2M |
|
Cephalon Disclosed: Jan. 2009 to June 2013 |
$99.6M |
|
Eli Lilly Disclosed: Jan. 2009 to Dec. 2013 |
$811.7M |
|
EMD Serono Disclosed: Jan. 2011 to Dec. 2013 |
$8.1M |
|
Forest Disclosed: Jan. 2012 to Dec. 2013 |
$208.8M |
|
GlaxoSmithKline Disclosed: April 2009 to Dec. 2013 |
$437.9M |
|
Johnson & Johnson Disclosed: Jan. 2010 to Dec. 2013 |
$100.5M |
|
Merck Disclosed: July 2009 to Dec. 2013 |
$724.3M |
|
Novartis Disclosed: Oct. 2010 to Dec. 2013 |
$198.6M |
|
Pfizer Disclosed: July 2009 to Dec. 2013 |
$745.2M |
|
UCB Disclosed: Jan. 2012 to Dec. 2013 |
$56.5M |
|
Valeant Disclosed: Jan. 10, 2010 to Dec. 2013 |
Ranges* |
|
ViiV Disclosed: Jan. 2010 to Dec. 2013 |
$38.6M |
Notes: Companies report different types of payments for different time periods. Payments made after December 2013 are not reflected on this website. Because they are reported in ranges, some of Valeant's payments and all of Allergan's payments are excluded from state and national totals. No payments are listed for Novartis from Oct. 1, 2011 to Dec. 31, 2011 or for Valeant between Sept. 27, 2010 and Jan. 1, 2011.
Our Stories
What We’ve Learned from Four Years of Diving into Dollars for Docs
Payments from pharmaceutical companies touch hundreds of thousands of doctors. The 17 companies we’ve tracked spent $1.4 billion in 2013 alone. Here are our top five takeaways from following all that money.
As Full Disclosure Nears, Doctors’ Pay for Drug Talks Plummets
As transparency increases and blockbuster drugs lose patent protection, drug companies have dramatically scaled back payments to doctors for promotional talks.
Dollars for Docs Mints a Millionaire
New data show drugmakers' payments to hundreds of thousands of doctors, and some have made well over $500,000.
Background Stories
Big Pharma’s Big FinesReporters, Use Our Data
Have questions about how you can best use Dollars for Docs for your own localized reporting? Contact Nicole Collins Bronzan at [email protected].
Additional reporting and development by Jason Das, Liz Day, David Frackman, Jennifer LaFleur, Jeff Larson, Dan Nguyen, Mike Tigas and Sisi Wei. Pharmacy icon from The Noun Project. The 2012 market share for the companies included in this tool was calculated using data from IMS Health, a health care information company.